FIELD: medicine.
SUBSTANCE: ranimizumab is injected through a two-stage self-sealing scleral puncture with a 30G injection needle into a vitreous body at 3.5-4.0mm from the limb. A control optical coherent tomography and a fluorescent angiography of the retina are performed 2-3 weeks later. The persistent ischemia and extravasation regions require a paravasal transpupillar laser retinal coagulation to be performed. The exposure parameters: wave length 659nm, power 0.13-0.15mWt, 100-250 coagulates, exposure 0.1-0.15 s, spot diameter 200mcm. The retina is exposed along the temporal arcades.
EFFECT: method enables providing the stable therapeutic effect ensured by relieving or eliminating a macular oeodema with improving the visual functions by suppressing the extravasation and blocking of the ischemic regions in a combination with reducing the anti-inflammatory and haemorrhagic reaction.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR COMBINATION THERAPY OF RETINOVASCULAR MACULAR OEDEMA | 2013 |
|
RU2527360C1 |
| COMPLEX METHOD OF MACULAR OEDEMA TREATMENT IN RETINAL VEIN OCCLUSIONS | 2019 |
|
RU2718847C1 |
| METHOD FOR COMPREHENSIVE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH OCCLUSION OF BRANCH OF CENTRAL RETINAL VEIN WITH OCT CONTROL IN REAL TIME | 2019 |
|
RU2749122C1 |
| METHOD FOR PREVENTION OF DIABETIC RETINOPATHY PROGRESSION IN PREGNANT WOMEN WITH DIABETES MELLITUS | 2023 |
|
RU2814772C1 |
| METHOD FOR THE TREATMENT OF MACULAR EDEMA DUE TO OCCLUSION OF A BRANCH OF THE CENTRAL RETINAL VEIN IN COMBINATION WITH RETINAL ARTERIOLAR MACROANEURYSM | 2021 |
|
RU2762991C1 |
| METHOD OF TREATING AN ILZE'S DISEASE | 2018 |
|
RU2696045C1 |
| METHOD OF TREATING NEOVASCULAR GLAUCOMA | 2013 |
|
RU2575966C2 |
| METHOD OF TREATING DISEASES OF EYE RETINA IN CASE OF DIABETES MELLITUS | 2010 |
|
RU2452443C1 |
| METHOD FOR CYSTIC MACULAR EDEMA LASER TREATMENT | 2016 |
|
RU2622378C1 |
| METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
